Analysts See $-0.25 EPS for Infinity Pharmaceuticals, Inc. (INFI); Zebra Capital Management Has Trimmed By $374,010 Its Herman Miller Com Stk (MLHR) Stake

February 19, 2018 - By Louis Casey

Analysts expect Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) to report $-0.25 EPS on March, 13.They anticipate $0.21 EPS change or 45.65% from last quarter’s $-0.46 EPS. After having $-0.14 EPS previously, Infinity Pharmaceuticals, Inc.’s analysts see 78.57% EPS growth. It closed at $1.86 lastly. It is down 60.96% since February 19, 2017 and is downtrending. It has underperformed by 77.66% the S&P500.

Zebra Capital Management Llc decreased Herman Miller Inc Com Stk (MLHR) stake by 13.79% reported in 2017Q3 SEC filing. Zebra Capital Management Llc sold 10,686 shares as Herman Miller Inc Com Stk (MLHR)’s stock rose 5.47%. The Zebra Capital Management Llc holds 66,817 shares with $2.40 million value, down from 77,503 last quarter. Herman Miller Inc Com Stk now has $2.22B valuation. The stock decreased 1.59% or $0.6 during the last trading session, reaching $37.25. About 199,392 shares traded. Herman Miller, Inc. (NASDAQ:MLHR) has risen 6.46% since February 19, 2017 and is uptrending. It has underperformed by 10.24% the S&P500.

Zebra Capital Management Llc increased Milacron Holdings Corp stake by 18,971 shares to 65,608 valued at $1.11M in 2017Q3. It also upped Cdk Global Inc (NASDAQ:CDK) stake by 7,915 shares and now owns 11,697 shares. Amkor Technology Inc Com Stk (NASDAQ:AMKR) was raised too.

Among 4 analysts covering Herman Miller (NASDAQ:MLHR), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Herman Miller had 6 analyst reports since December 18, 2015 according to SRatingsIntel. The rating was initiated by Seaport Global with “Neutral” on Friday, November 4. Sidoti initiated the shares of MLHR in report on Tuesday, June 27 with “Buy” rating. As per Friday, December 18, the company rating was downgraded by Raymond James. The stock has “Underperform” rating by Raymond James on Tuesday, January 3. Raymond James upgraded Herman Miller, Inc. (NASDAQ:MLHR) rating on Tuesday, December 26. Raymond James has “Buy” rating and $43.0 target. As per Friday, June 24, the company rating was downgraded by BB&T Capital.

Since August 21, 2017, it had 0 buys, and 11 insider sales for $4.52 million activity. Veltman Kevin J. sold $47,927 worth of stock. Another trade for 4,091 shares valued at $139,000 was made by Ramirez Michael F. on Wednesday, September 27. WALKER BRIAN C sold $458,220 worth of Herman Miller, Inc. (NASDAQ:MLHR) on Monday, August 21. On Wednesday, September 27 Lopez Hezron T. sold $186,552 worth of Herman Miller, Inc. (NASDAQ:MLHR) or 5,353 shares. Gane Stephen C sold $352,641 worth of Herman Miller, Inc. (NASDAQ:MLHR) on Tuesday, January 16. The insider LOCK ANDREW J sold 24,277 shares worth $829,564.

Investors sentiment increased to 1.36 in 2017 Q3. Its up 0.07, from 1.29 in 2017Q2. It is positive, as 15 investors sold MLHR shares while 68 reduced holdings. 37 funds opened positions while 76 raised stakes. 47.85 million shares or 1.06% less from 48.36 million shares in 2017Q2 were reported. Citigroup Inc invested in 33,930 shares. Fifth Third Bancshares holds 0% or 1,132 shares in its portfolio. Deprince Race & Zollo invested in 44,801 shares. Vulcan Value Prtnrs Limited Company invested in 0.31% or 1.00 million shares. Victory Capital Mngmt Inc invested in 22,530 shares. Wheatland Advsrs holds 0.2% of its portfolio in Herman Miller, Inc. (NASDAQ:MLHR) for 6,400 shares. Asset Mngmt One owns 7,422 shares for 0% of their portfolio. Fuller & Thaler Asset has 0.63% invested in Herman Miller, Inc. (NASDAQ:MLHR) for 1.42M shares. Dekabank Deutsche Girozentrale invested 0.01% in Herman Miller, Inc. (NASDAQ:MLHR). Amer Group owns 162,366 shares. 6.13 million are owned by Blackrock. Jane Street Gru Limited Company stated it has 7,663 shares or 0% of all its holdings. The Georgia-based Suntrust Banks Inc has invested 0.02% in Herman Miller, Inc. (NASDAQ:MLHR). Trillium Asset Management Limited Co has 0.17% invested in Herman Miller, Inc. (NASDAQ:MLHR). Swiss National Bank has invested 0% in Herman Miller, Inc. (NASDAQ:MLHR).

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for patients with difficult-to-treat diseases in the United States. The company has market cap of $94.32 million. The Company’s lead product candidate includes IPI-549 an orally administered immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma is in Phase 1 clinical study. It currently has negative earnings. The firm has a license agreement with Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib, a selective inhibitor of the PI3K delta and gamma isoforms, including DUO study that is in randomized Phase III clinical study for patients with relapsed/refractory chronic lymphocytic leukemia and products containing duvelisib; Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; and Takeda Pharmaceutical Company Limited to develop and commercialize duvelisib.

Since October 3, 2017, it had 1 buying transaction, and 0 sales for $2.01 million activity. BVF PARTNERS L P/IL had bought 1.60M shares worth $2.01M on Tuesday, October 3.

Investors sentiment decreased to 0.47 in 2017 Q3. Its down 0.16, from 0.63 in 2017Q2. It fall, as 15 investors sold Infinity Pharmaceuticals, Inc. shares while 23 reduced holdings. 6 funds opened positions while 12 raised stakes. 27.30 million shares or 18.05% less from 33.31 million shares in 2017Q2 were reported. Art Ltd Llc owns 181,220 shares. 182,380 are held by Qs Limited Liability Corporation. Wells Fargo & Mn has 0% invested in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) for 13,930 shares. Group holds 0.01% or 40,000 shares in its portfolio. North Carolina-based National Bank Of America Corp De has invested 0% in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI). Royal State Bank Of Canada has 1,500 shares for 0% of their portfolio. Blackrock invested in 0% or 1.01M shares. Retail Bank Of New York Mellon invested in 45,985 shares. Tortoise Investment Limited Liability stated it has 100 shares or 0% of all its holdings. Bogle Invest Mngmt Limited Partnership De owns 224,793 shares. Barclays Public Ltd Com, United Kingdom-based fund reported 1,096 shares. 580,400 were reported by Baker Bros Advsr Ltd Partnership. Two Sigma Ltd Liability stated it has 0% of its portfolio in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI). 3,876 were reported by Federated Inc Pa. Northern Tru Corp owns 379,443 shares.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>